Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Gains from Investment Securities: 2022-2023

Historic Gains from Investment Securities for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to $105,000.

  • Lexeo Therapeutics' Gains from Investment Securities fell 2.78% to $105,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $425,000, marking a year-over-year change of. This contributed to the annual value of $410,000 for FY2024, which is 3.53% down from last year.
  • Latest data reveals that Lexeo Therapeutics reported Gains from Investment Securities of $105,000 as of Q4 2023, which was down 1.87% from $107,000 recorded in Q3 2023.
  • In the past 5 years, Lexeo Therapeutics' Gains from Investment Securities ranged from a high of $110,000 in Q1 2023 and a low of $36,000 during Q3 2022.
  • In the last 2 years, Lexeo Therapeutics' Gains from Investment Securities had a median value of $106,000 in 2023 and averaged $94,833.
  • The largest annual percentage gain for Lexeo Therapeutics' Gains from Investment Securities in the last 5 years was 197.22% (2023), contrasted with its biggest fall of 2.78% (2023).
  • Quarterly analysis of 2 years shows Lexeo Therapeutics' Gains from Investment Securities stood at $108,000 in 2022, then dropped by 2.78% to $105,000 in 2023.
  • Its Gains from Investment Securities stands at $105,000 for Q4 2023, versus $107,000 for Q3 2023 and $103,000 for Q2 2023.